Schizophrenia Research
Volume 45, Issue 3 , Pages 203-211, 27 October 2000

Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia

  • Kriscinda A. Marks

      Affiliations

    • Indiana Univeristy — Purdue University Indianapolis, IN (IUPUI), 402 N. Blackford Street, LD124 Indianapolis, IN 46202, USA
  • ,
  • Philip S. Fastenau

      Affiliations

    • Indiana Univeristy — Purdue University Indianapolis, IN (IUPUI), 402 N. Blackford Street, LD124 Indianapolis, IN 46202, USA
    • Corresponding Author InformationCorresponding author
  • ,
  • Paul H. Lysaker

      Affiliations

    • Department of Veterans' Affairs Medical Center, Rondebush VA Medical Center (116H), 1481 West 10th Street, Indianapolis, IN 46202, USA
    • Indiana University School of Medicine, Indianapolis, IN, USA
  • ,
  • Gary R. Bond

      Affiliations

    • Indiana Univeristy — Purdue University Indianapolis, IN (IUPUI), 402 N. Blackford Street, LD124 Indianapolis, IN 46202, USA

Received 16 April 1999; accepted 29 September 1999.

Abstract 

The Self-Appraisal of Illness Questionnaire (SAIQ) is a self-report instrument designed to assess attitudes toward mental illness among persons receiving psychiatric treatment. This instrument was developed for use in community settings, adapted closely from the Patient's Experience of Hospitalization questionnaire. In order to examine the validity of the SAIQ, a factor analysis was first conducted on the items of this instrument in a sample of 59 outpatients with schizophrenia or schizoaffective illness. Three factors emerged: Need for Treatment, Worry, and Presence/Outcome of Illness. Next, to examine the concurrent validity of these three SAIQ subscales, they were correlated with researcher rated insight scales and neuropsychological tests. Results indicated that the Need for Treatment and Presence/Outcome subscales were significantly correlated with both researcher-rated insight scales and with neuropsychological tests of executive functioning. The Worry subscale was not associated with either researcher-rated insight scales or neuropsychological tests. It was concluded that the Need for Treatment and Presence/Outcome subscales may be used in combination as a brief screening instrument for clients with schizophrenia receiving outpatient psychiatric treatment who may be at risk for treatment non-compliance due to a lack of insight into illness.

Keywords:  Insight, Schizophrenia, Neuropsychological assessment, Cognition

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This manuscript is an elaboration of a paper that was presented at the Annual Meeting of the American Psychological Association in Boston, Massachusetts, USA, in August 1999 (Marks, Fastenau, Lysaker, & Bond, 1999).

PII: S0920-9964(99)00208-X

Schizophrenia Research
Volume 45, Issue 3 , Pages 203-211, 27 October 2000